344 related articles for article (PubMed ID: 10884562)
1. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: II. In vitro studies in the rat.
Béïque J; de Montigny C; Blier P; Debonnel G
Neuropharmacology; 2000 Jul; 39(10):1813-22. PubMed ID: 10884562
[TBL] [Abstract][Full Text] [Related]
2. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat.
Béïque J; de Montigny C; Blier P; Debonnel G
Neuropharmacology; 2000 Jul; 39(10):1800-12. PubMed ID: 10884561
[TBL] [Abstract][Full Text] [Related]
3. Effect of long-term administration of duloxetine on the function of serotonin and noradrenaline terminals in the rat brain.
Rueter LE; Kasamo K; de Montigny C; Blier P
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):600-10. PubMed ID: 9686935
[TBL] [Abstract][Full Text] [Related]
4. Modification of serotonin neuron properties in mice lacking 5-HT1A receptors.
Richer M; Hen R; Blier P
Eur J Pharmacol; 2002 Jan; 435(2-3):195-203. PubMed ID: 11821026
[TBL] [Abstract][Full Text] [Related]
5. Modulation of 5-HT release in the guinea-pig brain following long-term administration of antidepressant drugs.
Blier P; Bouchard C
Br J Pharmacol; 1994 Oct; 113(2):485-95. PubMed ID: 7834200
[TBL] [Abstract][Full Text] [Related]
6. S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
Millan MJ; Gobert A; Lejeune F; Newman-Tancredi A; Rivet JM; Auclair A; Peglion JL
J Pharmacol Exp Ther; 2001 Aug; 298(2):565-80. PubMed ID: 11454918
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiological characterization of the effect of long-term duloxetine administration on the rat serotonergic and noradrenergic systems.
Rueter LE; De Montigny C; Blier P
J Pharmacol Exp Ther; 1998 May; 285(2):404-12. PubMed ID: 9580577
[TBL] [Abstract][Full Text] [Related]
8. Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors.
Bymaster FP; Dreshfield-Ahmad LJ; Threlkeld PG; Shaw JL; Thompson L; Nelson DL; Hemrick-Luecke SK; Wong DT
Neuropsychopharmacology; 2001 Dec; 25(6):871-80. PubMed ID: 11750180
[TBL] [Abstract][Full Text] [Related]
9. Effect of acute, short- and long-term milnacipran administration on rat locus coeruleus noradrenergic and dorsal raphe serotonergic neurons.
Mongeau R; Weiss M; de Montigny C; Blier P
Neuropharmacology; 1998 Jul; 37(7):905-18. PubMed ID: 9776386
[TBL] [Abstract][Full Text] [Related]
10. S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
Millan MJ; Dekeyne A; Papp M; La Rochelle CD; MacSweeny C; Peglion JL; Brocco M
J Pharmacol Exp Ther; 2001 Aug; 298(2):581-91. PubMed ID: 11454919
[TBL] [Abstract][Full Text] [Related]
11. Venlafaxine: discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites.
Béïque JC; de Montigny C; Blier P; Debonnel G
Synapse; 1999 Jun; 32(3):198-211. PubMed ID: 10340630
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of 5-HT1D autoreceptors on the modulation of 5-HT release in guinea-pig mesencephalic raphe, hippocampus and frontal cortex.
el Mansari M; Blier P
Br J Pharmacol; 1996 Jun; 118(3):681-9. PubMed ID: 8762094
[TBL] [Abstract][Full Text] [Related]
13. Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters.
Béïque JC; Lavoie N; de Montigny C; Debonnel G
Eur J Pharmacol; 1998 May; 349(1):129-32. PubMed ID: 9669506
[TBL] [Abstract][Full Text] [Related]
14. Potentiation by (-)Pindolol of the activation of postsynaptic 5-HT(1A) receptors induced by venlafaxine.
Béïque JC; Blier P; de Montigny C; Debonnel G
Neuropsychopharmacology; 2000 Sep; 23(3):294-306. PubMed ID: 10942853
[TBL] [Abstract][Full Text] [Related]
15. The effects of selective serotonin reuptake inhibitors on extracellular 5-HT levels in the hippocampus of 5-HT(1B) receptor knockout mice.
De Groote L; Olivier B; Westenberg HG
Eur J Pharmacol; 2002 Mar; 439(1-3):93-100. PubMed ID: 11937097
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study.
Beyer CE; Boikess S; Luo B; Dawson LA
J Psychopharmacol; 2002 Dec; 16(4):297-304. PubMed ID: 12503828
[TBL] [Abstract][Full Text] [Related]
17. Neurotransmitter release and its presynaptic modulation in the rat hippocampus after selective damage to cholinergic or/and serotonergic afferents.
Birthelmer A; Ehret A; Amtage F; Förster S; Lehmann O; Jeltsch H; Cassel JC; Jackisch R
Brain Res Bull; 2003 Jan; 59(5):371-81. PubMed ID: 12507688
[TBL] [Abstract][Full Text] [Related]
18. Blockade of 5-hydroxytryptamine and noradrenaline uptake by venlafaxine: a comparative study with paroxetine and desipramine.
Béïque JC; de Montigny C; Blier P; Debonnel G
Br J Pharmacol; 1998 Oct; 125(3):526-32. PubMed ID: 9806336
[TBL] [Abstract][Full Text] [Related]
19. Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers.
Blier P; Saint-André E; Hébert C; de Montigny C; Lavoie N; Debonnel G
Int J Neuropsychopharmacol; 2007 Feb; 10(1):41-50. PubMed ID: 16690005
[TBL] [Abstract][Full Text] [Related]
20. Effects of chronically administered venlafaxine on 5-HT receptor activity in rat hippocampus and hypothalamus.
Gur E; Dremencov E; Van De Kar LD; Lerer B; Newman ME
Eur J Pharmacol; 2002 Feb; 436(1-2):57-65. PubMed ID: 11834247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
